Patent · US Active

Aryl ether-base kinase inhibitors

US8703953B2 · kind B2 · utility

1Cited by

0References

8Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Vivekananda M. Vrudhula · Killingworth, US
Senliang Pan · Woodbridge, US
Ramkumar Rajamani · Wallingford, US
John E. Macor · Guilford, US
Joanne J. Bronson · Madison, US
Carolyn Diane Dzierba · Middletown, US
Susheel Jethanand Nara · Mumbai, IN
Maheswaran Sivasamban Karatholuvhu · Chennai, IN

Key dates

Filing date	Feb 26, 2013
Grant date	Apr 22, 2014
Priority date	—
Expiry date	Feb 26, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure is generally directed to compounds which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds, and methods for inhibiting AAK1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.